Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of ...
The FDA has granted breakthrough therapy designation (BTD) to soficabtagene geleucel (sofi-cel; WU-CART-007) for the ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
Cipla has partnered with ImmunoACT to introduce the CAR-T cell therapy 'talicabtagene autoleucel' in South Africa, Algeria, ...
Cipla partners with ImmunoAct to introduce India’s first CAR-T cell therapy in Africa, enhancing accessible cancer treatment ...
The Gift of Life Marrow Registry's 15th annual Steps for Life 5K in South Florida will feature a heartwarming introduction ...
Cipla partners with ImmunoACT to commercialise CAR-T cell therapy in South Africa, Algeria, and Morocco. Expanding access to innovative cancer treatment.
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Mackenzie Paul, who first went viral in August 2023 after sharing her cancer diagnosis on TikTok, has died at 26.
Cipla Limited, through its subsidiary Medpro Pharmaceutica, has entered into an exclusive license and supply agreement with ...
Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...